Clinical outcome of high-dose bolus intravenous interleukin-2 with a modified administration schedule for Asian patients with metastatic renal cell carcinoma
Crossref DOI link: https://doi.org/10.1007/s00280-016-3222-4
Published Online: 2016-12-23
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Ji Young
Song, Cheryn
Hong, Bum Sik
Hong, Jun Hyuk
Ahn, Hanjong
Lee, Jae Lyun
Funding for this research was provided by:
Ministry of Health and Welfare, Korea (HI12C1788, HI14C1061, HI14C1931, HI14C1731)
License valid from 2016-12-23